The Ministry of Health approved trials of the Sputnik M vaccine on children

The tests will be carried out by the Gamaleya National Research Center for Epidemiology and Microbiology. They will be completed by the end of 2023.

The study will evaluate the safety of this drug for children, its tolerability and immunogenicity.

Earlier it was noted that 2.2 thousand volunteers will be recruited to participate in the study. Research will be carried out in the Morozov Children's Clinical Hospital, Children's City Clinical Hospital. Bashlyaeva and at the Sechenov Medical University.

Recall that the Sputnik M vaccine was registered in November 2021. It was allowed to be used by teenagers aged 12 to 17 years. Now in the center Gamaleya intend to study the possibility of using the vaccine on children from six to 11 years old.

The Sputnik M vaccine is no different from the adult Sputnik V vaccine, except for the dosage of the drug. In a vaccine for adolescents, it is five times lower; in a vaccine for children, it will be 10 times lower.

As Deputy Prime Minister Tatyana Golikova previously reported , teenagers under the age of 15 will be vaccinated only after obtaining the consent of their parents. Children over the age of 15 will make their own decision about vaccinations.